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Abstract 
PURPOSE: The goals of this study were to: improve delirium recognition by implementing the 
Confusion Assessment Method for the ICU (CAM-ICU), evaluate adherence to routine delirium 
monitoring, measure the incidence of CAM-positive patients, and measure the use of analgesic 
and sedative medications in ICU patients. 
METHODS: This study was a single-center post-implementation retrospective medical record 
review examining the adherence and incidence of delirium after the introduction of the CAM-
ICU assessment on the surgical ICU. Prior to the beginning of the study the surgical ICU nurses 
were educated on how to assess for delirium using the CAM-ICU instrument. During the six 
week study the following data were collected: adherence to delirium monitoring through 
documentation, incidence of CAM-positive patients, and sedation and analgesic medication 
usage. The sample consisted of seventy-six patients that were admitted to the surgical ICU 
between September 6, 2016 and October 18, 2016.    
RESULTS:  Thirty-two (58.1%) patients had the CAM-ICU assessment completed once a shift 
at the 48-hour evaluation and twenty-two (81.4%) patients during the 96-hour evaluation. Five 
(9%) patients were CAM-positive at the 48-hour and one (3.7%) at the 96-hour evaluation. The 
48-hour time interval had the highest average number of dosages for analgesic medications at 2.3 
(29.4%) for CAM-negative patients. CAM-positive analgesic medications usage increased 
progressively, peaking at the 72-hour interval with the average dose at 3.6 (32.1%). With regards 
to sedative medications, CAM-negative patients had the highest average number of dosages, 1.9 
(30.2%), at the 48-hour interval. For CAM-positive patients the use of sedative medications 
peaked at the 24-hour interval and then decreased at the 48-hour time frame; after which sedative 
medication usage rose steadily from the 48 through 96-hour interval.
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CONCLUSION: Required routine delirium monitoring should occur per evidence-based 
practice guidelines for all ICU patients. The incidence of delirium in this study was found to be 
low, at 9%, when compared to previous studies on delirium. No statistically significant 
conclusions could be drawn from this study. Factors that could have contributed to this low 
incidence of delirium in these specific patients could have been the relative young age of the 
patients (mean age of 53.2) and the possible lower severity of illness, both of these factors 
influence the risk of delirium development. In conclusion, this single study may have found a 
low incidence of delirium among these specific ICU patients but many previous studies have 
determined that the incidence of delirium is much higher. 
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Monitoring for Delirium in the Intensive Care Unit Following the Introduction of the Confusion 
Assessment Method for the Intensive Care Unit 
Introduction 
As the population ages, more people will require treatment of acute conditions in the 
hospital. This increased encounter of the aging population with a more intensive treatment of 
medical problems is believed to result in an increase in the prevalence of delirium among this 
population (Angus, Kelley, Schmitz, White, & Popovich, 2000).  One of the major objectives for 
improvement in the quality of care for the aging adult population is the improvement of 
recognizing, treating and preventing delirium (Vincent et al., 1998). This objective was identified 
almost twenty years ago but delirium still remains an enormous issue that is often not recognized 
and treated within the health care system (Barr et al., 2013). Pandharipande, Jackson, and Ely 
(2005) identified a high incidence of delirium among intensive care unit (ICU) patients. Current 
evidence-based practice recommends routine delirium monitoring using a valid and reliable 
diagnostic tool once a shift (every twelve hours) for all ICU patients (Barr et al., 2013). 
Therefore, the goals of this study were to: improve delirium recognition by implementing the 
Confusion Assessment Method for the ICU (CAM-ICU), evaluate adherence to routine delirium 
monitoring, measure the incidence of CAM-positive patients, and measure the use of analgesic 
and sedative medications in ICU patients (see figure 1 for CAM-ICU assessment flowsheet).      
Background 
Delirium is defined as an “acute, fluctuating change in mental status, with inattention and 
altered level of consciousness” (Pandharipande et al., 2005, p. 360). In the past this condition 
was viewed as a normal occurrence brought about by the ICU environment, which resulted in 
providers failing to recognize delirium as a serious medical diagnosis (Pandharipande et al., 
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2005). This study also concluded that “delirium is not only a marker of end-organ damage but 
also acts directly as a promoter of other organ systems dysfunctions” (p. 360). The typical ICU 
patient has 10 or more risk factors, e.g. age, severity of illness, and the use of 
sedatives/analgesics medications, for the development of delirium (Pandharipande et al., 2006).   
Delirium is unrecognized in up to 66% of ICU patients and has an estimated incidence up 
to 80% (Arend & Christensen, 2009; Pandharipande et al., 2005). These studies found that a 
failure to recognize and/or treat delirium appropriately in the ICU has led to negative patient 
outcomes. Specifically, Pandharipande et al. (2005) found an “increased mortality of 25 to 33% 
and a three times greater risk of discharge to a nursing home” (p. 363). While increased medical 
costs, a 49% increased length of stay (LOS) compared to non-delirious patents, and increased 
stress for family members and medical staff have also been linked to delirium (Arend & 
Christensen, 2009; Robinson et al., 2008).  
Pandharipande et al. (2006) point out, patients are commonly being prescribed a 
benzodiazepine, like Lorazepam, which has been linked to further exacerbation of delirium. This 
study included 198 ICU patients and found that “Lorazepam was an independent risk factor for 
daily transition to delirium” and “the probability of the transition to delirium is 100%”, when 
20mg or more is given in a 24-hour period (p.23). Additionally, this study investigated Versed, 
Morphine, Fentanyl and Propofol all of which were associated with delirium development but 
the findings were not statistically significant like Lorazepam.    
A key factor in improving delirium recognition is engagement of nurses and providers to 
routinely monitor for delirium using a reliable and valid bedside diagnostic instrument 
(Pandharipande et al., 2005). The Society of Critical Care Medicine recommends the use of the 
CAM-ICU because it is the most specific and reliable diagnostic instrument, with a specificity of 
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96% and sensitivity of 80% (Gusmao-Flores, Figueira Salluh, Chalhub, & Quarantini, 2012; 
Luetz et al., 2010; Olson, 2012). However, Eastwood, Peck, Bellomo, Baldwin, and Reade 
(2012) found that only 20% of ICU nurses knew that there was a diagnostic instrument to detect 
delirium, and even then, only 7% sometimes assessed for delirium using the instrument. 
Therefore, implementing the CAM-ICU assessment in the ICU can improve delirium recognition 
among ICU patients.      
Purpose 
According to Barr et al. (2013) the current evidence-based practice is to routinely monitor 
patients for delirium using a standardized diagnostic tool in the ICU setting. The purpose of this 
study was to implement delirium monitoring for ICU patients using a standardized diagnostic 
tool in the surgical ICU. Adherence and incidence of CAM-positive patients will be measured 
along with the type, route of administration, and frequency of sedative and analgesia medications 
administered at 24, 48, 72, and 96-hours following admission. Currently, the University of 
Louisville Hospital does not use a standard diagnostic tool to assess for delirium. For this study, 
the nurses on the surgical ICU were educated on the CAM-ICU instrument for routine 
monitoring of delirium among surgical ICU patients. The specific aims of this study were: 
1) To provide nurses with a standardized delirium diagnostic tool to monitor for 
delirium  
2) To evaluate adherence to routine delirium after the introduction of the CAM-ICU 
assessment     
3) To evaluate the incidence of CAM-positive patients on the surgical ICU at 48 and 96 
hours post admission  
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4) To determine the type, route of administration, and frequency of sedative and 
analgesic medications administered at 24, 48, 72, and 96 hours post admission.   
Methods 
Prior to the study beginning, approval was obtained from the University of Kentucky 
Institutional Review Board (IRB) and the University of Louisville IRB. Authorization to conduct 
the study on the surgical ICU was acquired from the clinical manager. This study was a single-
center, post-implementation, retrospective descriptive medical record review examining the 
impact of delirium monitoring, via the CAM-ICU tool, on patients admitted to the surgical ICU 
at the University of Louisville Hospital. After education was given to the surgical ICU nurses on 
how to assess for delirium using the CAM-ICU instrument, daily delirium assessments were 
conducted on each patient admitted to the surgical ICU for a six week period. The following data 
were collected during the six week study time frame: adherence to delirium monitoring through 
documentation, incidence of CAM-positive patients, and sedation and analgesic medication 
usage.  
Setting 
The University of Louisville Hospital is a level one academic medical center located in 
downtown Louisville, Kentucky. This is a 404-bed acute care hospital that admits patients from 
all over Kentucky and southern Indiana. The focus of this study was the ten-bed surgical ICU, 
which typically treats surgical patients, i.e. vascular, colorectal, elective surgery, and surgical 
oncology. Trauma patients are also commonly admitted to this ICU with injuries occurring from 
gunshot wounds, motor vehicle accidents, motorcycle accidents, and falls. In addition to those 
patients, this ICU admits overflow medical and neurosurgery ICU patients.               
 




This sample contained the medical records of 78 patients admitted to the surgical ICU 
post implementation of the CAM-ICU assessment tool. Since delirium can affect any ICU 
patient, the population of interest for this study was any ICU patients admitted to the surgical 
ICU. Included in this study were: those patients, at least 18 years of age, who were admitted to 
the surgical ICU between September 6, 2016 and October 18, 2016. Any patient under the age of 
18 was excluded from the study. One patient was removed due to being under the age of 18 and 
one was excluded due to being discharge from the surgical ICU on the day the study began, 
resulting in a total of 76 patients in the sample.   
Data Collection 
 After the six-week period was complete, a retrospective chart review was conducted. 
Patients for the study were identified by electronically searching for patients admitted to the 
surgical ICU on the study dates. The patients’ medical record numbers were then used to extract 
data from the electronic medical record (EMR) and the data were then transposed into an 
electronic spreadsheet. No patient identifiers were contained within this spreadsheet; all patients 
were assigned numbers (1-76) for the protection of protected health information (PHI). 
Demographic variables such as age, sex, race and admitting service were obtained from the data.  
Implementation of Delirium Monitoring  
One aim of this study was to implement routine delirium monitoring for ICU patients on 
the surgical ICU at the University of Louisville Hospital. The week prior to the initiation of the 
study, all of the surgical ICU nurses on both shifts were instructed by the principle investigator 
(PI) on how to detect delirium using the CAM-ICU assessment tool. The EMR used by the 
hospital allowed for documentation of the CAM-ICU assessment within the patient’s EMR. The 
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nurses were instructed, by the PI, on where documentation of the daily delirium assessments 
needed to be recorded. Signs were placed around the unit to remind the nurses to conduct a 
delirium assessment once a shift, along with flowsheets on how to assess patients using the 
CAM-ICU assessment. Delirium monitoring continued for the next six weeks once a shift (8 a.m. 
and 8 p.m.) for all patients admitted to the surgical ICU (see figure 1 for CAM-ICU assessment 
flowsheet).  
Adherence to Delirium Monitoring 
By reviewing the EMR the PI verified delirium monitoring occurred once a shift at the 48 
and 96-hour post admission to the surgical ICU time intervals in all patients whose EMR were 
reviewed. The data were broken down into four categories: documentation occurred twice in the 
24-hour period within 48 and 96-hour following admission to the ICU, documentation only once 
in a 24-hour period, no documentation of delirium assessment, or patient discharged prior to 48 
or 96-hour evaluation. If the patient had a documented CAM-ICU assessment in the EMR at 8 
a.m. and 8 p.m. in the 48 or 96-hour interval then the data was recorded as two out of two 
assessments completed. If the patient only had one document CAM-ICU assessment in the EMR 
at either 8 a.m. or 8 p.m. in the 48 or 96-hour interval then the data was recorded as one out of 
two assessment completed. If the CAM-ICU assessment was not documented within the EMR at 
8 a.m. and 8 p.m. in the 48 or 96-hour interval then the data was recorded as zero out of two 
assessments completed. If the patient had been discharge prior to the 48 or 96-hour intervals then 
it was recorded that the patient was not assessed using the CAM-ICU assessment due to the 
patient being discharged from the surgical ICU.        
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CAM-ICU Results  
As with the adherence to delirium monitoring, the CAM-ICU results were measured at 48 
and 96 hours post admission to the surgical ICU. CAM-ICU results required at least one 
documented CAM-ICU assessment in the patients EMR at either 8 a.m. or 8 p.m. The data were 
broken down into five categories: CAM-ICU negative, CAM-ICU positive, unable to assess, no 
documentation completed, or discharged prior to evaluation. CAM-ICU negative are patients that 
the CAM-ICU assessment determined that delirium was not present. These patients were 
determined to be CAM-ICU negative at either the 48 or 96-hour interval by a documented CAM-
ICU negative assessment in the EMR at 8 a.m. and/or 8 p.m. CAM-positive patients were 
defined as a patient that tested positive for delirium using the CAM-ICU assessment at the 48 or 
96-hour interval. These patients required CAM-ICU positive documentation in the EMR at 8 
a.m. and/or 8 p.m. The unable to assess category occurred when the patient’s neurological status 
was not suitable, either due to medications or injuries, to conduct the CAM-ICU assessment at 
the 48 or 96-hour interval. The nurses determined if a patient was not suitable for the CAM-ICU 
assessment using the CAM-ICU flowsheet; documentation that assessment was not appropriate 
was required in the patient’s EMR at 8 a.m. and/or 8 p.m. to be included in the unable to assess 
category. If documentation did not occur for the CAM-ICU assessment in the EMR at 8 a.m. or 8 
p.m. in the 48 or 96-hour interval then the data was recorded as no CAM-ICU results. If the 
patient had been discharge prior to the 48 or 96-hour intervals then it was recorded that the 
patient was not assessed for delirium using the CAM-ICU assessment due to the patient being 
discharged from the surgical ICU (see figure 1 for CAM-ICU assessment flowsheet).        
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Administration of Sedation and/or Analgesic Medications 
Sedative and analgesic medications were specifically reviewed. Pandharipande et al. 
(2006) had found administering certain types of sedative and/or analgesic medication was 
associated with the development of delirium. Sedatives are defined as medications that depress 
central nervous activity, which reduces anxiety and induces sleep in patients. Typical sedative 
medications used in the ICU patient are classified as benzodiazepines, but others such as general 
anesthetics (Propofol) or alpha 2 adrenergic agonist (Precedex) can be administrated. Data were 
collected on any benzodiazepine patients received along with continuous infusions of Propofol or 
Precedex. Analgesics are defined as medications that provide relief from pain. Opioids, e.g. 
Morphine, Fentanyl and Dilaudid, are common analgesic administrated to ICU patients. 
Therefore, data were collected on any of these medications administered during the study. The 
data collected on all these medications included the type, route of administration, and frequency. 
Patients that were discharged prior to the 48-hour interval were excluded from this data 
collection because they had been discharged prior to the initial evaluation time frame for 
delirium using the CAM-ICU instrument. To determine the frequency of analgesic and/or 
sedative administration, the data were divided into four post admission time frames: 24, 48, 72, 
and 96 hours. From this a total number of dosages for analgesic and sedative medications for 
each time frame were extrapolated from the EMR.  
A comparison of the number of analgesic and/or sedative medications administered to 
CAM-positive patients in relation to the CAM-negative patients was conducted. To compare the 
data the average number of dosages for CAM-negative and CAM-positive patients at each time 
frame was determined. Due to certain medications being linked to delirium the percentage of the 
following medications administered to each group were collected: Fentanyl, Morphine, Versed, 
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Ativan and Propofol (Pandharipande et al., 2006). For the purpose of this comparison CAM-
positive patients were defined as a patient that tested positive for delirium at any point during the 
96-hour time interval. 
Data Analysis 
Descriptive statistics, e.g. measures of central tendency and variability, were used to 
analyze the data from this study. For adherence to delirium monitoring percentages were 
determined for the number of patients that met the following categories: documentation occurred 
twice in the 24-hour period within 48 and 96-hour following admission to the ICU, 
documentation only once in a 24-hour period, no documentation of delirium assessment, or 
patient discharged prior to 48 or 96-hour evaluation. CAM-ICU results were measured by the 
percentages of patients that met each of the following categories: CAM-ICU negative, CAM-
ICU positive, unable to assess, no documentation completed, or discharged prior to evaluation. 
Administration of sedation and/or analgesic medications were measured using percentage, mean 
and standard deviation.    
Results 
Sample Characteristics 
A total of 76 patient EMRs were reviewed. The mean age of the patients in this study was 
53.2 years old with males representing 56.6% (n=43) and females equaling 43.4% (n=33) of the 
total sample. The racial breakdown of the study was: 79% Caucasian (n=60), 15.8% African 
American (n=12), and 5.2% Other (n=4). The majority of patients (60.5%) on the surgical ICU 
were admitted to the trauma service. The next most frequent admitting service was the medical 
ICU (15.8%) and the neurosurgery service (11.8%) (see table 1 for the demographics of the 
sample).               
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Adherence to Delirium Monitoring 
Twenty-one (27.6%) of the 76 patients had been discharged from the surgical ICU prior 
to the 48-hour evaluation. Therefore, 55 patients remained on the surgical ICU at the 48-hour 
evaluation. Thirty-two (58.1%) of those patients had the CAM-ICU assessment completed twice 
in the 48-hour period following admission. At the 96-hour evaluation, 28 (51%) had been 
discharged from the surgical ICU, leaving 27 patients appropriate for data review. Of those, 22 
(81.4%) patients had the CAM-ICU assessment completed twice during the 96-hour evaluation 
(see table 2 for adherence to delirium monitoring).                  
CAM-ICU Results 
At the 48-hour evaluation, 55 of the original 76 patients were still admitted to the surgical 
ICU. Of those patients, 36 (65.5%) were determined to be CAM-ICU negative, while five (9%) 
patients tested positive for delirium using the assessment tool. When the data were reviewed for 
the 96-hour evaluation a total of 27 patients remained on the surgical ICU with 16 (59.2%) 
patients being CAM-ICU negative. In addition, one (3.7%) patient was found to be CAM-ICU 
positive at the 96-hour evaluation (see table 3 for CAM-ICU results). 
Of the five patients who tested positive for delirium 48 hours post admission, one of 
those patients tested positive again at the 96 hour interval. Of the other four CAM-positive 
patients, one expired on the unit, two were determined to be CAM-ICU negative at the 96-hour 
evaluation, and one was discharged prior to the 96 hour interval. The demographics of these 
CAM-positive patients were: three female, two male, all Caucasian, two admitted to the trauma 
service, two to the medical ICU, and one to neurosurgery.  
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Administration of Sedation and/or Analgesic Medications   
Twenty-one (27.6%) of the 76 patients had been discharged from the surgical ICU prior 
to the 48-hour evaluation. Therefore, 55 patients remained on the surgical ICU at the 48-hour 
evaluation. Six (10.9%) of the patients received no sedation or analgesic medication during the 
time intervals examined and 49 (89%) patients received some type of sedative or analgesic 
medication. The most common analgesics were intravenous Dilaudid and Morphine; both were 
equally administered to 20 (36.3%) patients. Norco represented the most common oral analgesic 
medication, being given to eighteen (32.7%) patients. Sedative medications were less frequently 
administered when compared with analgesics, 16 (13.8%) versus 100 (86.2%) respectively. 
Versed intravenous push was the most common sedative, with six (13.6%) patients receiving a 
dose during the time interval. A total of 19 (34.5%) patients received a continuous infusion of 
either an analgesic or sedative medication. The two most common continuous infusions 
administrated were the analgesic Fentanyl to ten (18.2%) of the patients and the sedative Versed 
to five (9%) of the patients. Excluding the continuous infusions, the majority medications 
(84.6%) were prescribed as PRN doses giving the nurse the ability to choose the type and 
number of times the medications were administrated. Of the total number of patients only 14 
(25.5%) received a scheduled dose of an analgesic, no scheduled intravenous push or oral 
sedatives were administered (see table 4 for a detailed breakdown of the types of medication 
administered).     
Overall, more dosages of analgesic medications were administered than sedative 
medications, 579 dosages (83.5 %) versus 114 dosages (16.5%). For analgesics, the time frame 
with the highest number of dosages was the 48-hour interval, with 173 (29.9%) dosages being 
administered. The amount of analgesics administered decreased after the 48-hour interval. 
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Sedative medications were administered the most during the 48-hour period, with 36 (31.6%) 
dosages given (see figure 2 for a graph of total number of dosages overtime).         
CAM-Negative versus CAM-Positive Patients  
In this study 36 (65.5%) patients were determined to be CAM-ICU negative, while five 
(9%) patients tested positive for delirium at the 48-hour evaluation using the assessment tool. 
The results for CAM-negative patients were consistent with the findings described in the 
previous section. The 48-hour time interval had the highest average number of dosages for 
analgesic medications at 2.3 (29.4%). The average number of dosages decrease after the 48-hour 
time interval. With regards to sedative medications and CAM-negative patients the highest 
average number of dosages, 1.9 (30.2%), occurred at the 48-hour interval. Sedative medication 
usage for this group remained comparatively low and consistent through the 96-hour time frame. 
In terms of specific medications that are linked to delirium development, 25%  of CAM-negative 
patients received Fentanyl, 23.6%  Morphine, 13.9% Versed, 5.6% Ativan and 8.3% Propofol 
(see figure 3 for the comparison of analgesic medications: CAM-positive vs. CAM-negative).  
CAM-positive patients’ results differed from CAM-negative patients. Their analgesic 
medications usage increased progressively, peaking at the 72-hour interval with the average dose 
at 3.6 (32.1%). The use of sedative medications peaked at the 24-hour interval then had a 
decreased at the 48-hour time frame; after which sedative medication usage rose steadily from 
the 48 through 96-hour interval. In terms of specific medications that are linked to delirium 
development, 20%  of CAM-positive patients received Fentanyl, 100%  Morphine, 40% Versed, 
20% Ativan and 0% Propofol (see figure 4 for the comparison of sedative medications: CAM-
positive vs. CAM-negative). 
 




The purpose of this study was to implement the evidence-based practice of routine 
delirium monitoring in the surgical ICU. Current guidelines recommend delirium monitoring at 
least once a shift (every twelve hours) for ICU patients using a valid standardized tool (Barr et 
al., 2013; Pandharipande et al., 2005). The surgical ICU at the University of Louisville Hospital 
was chosen to conduct this study because currently this hospital does not monitor patients for 
delirium. It was determined that delirium assessment would occur at 8 a.m. and 8 p.m. for every 
patient admitted to the surgical ICU using the CAM-ICU tool. Overall adherence to once a shift 
delirium monitoring occurred 58.1% of the time at the 48-hour interval and 81.4% of the time for 
the 96-hour interval. CAM-negative patients represented 65.5% and 59.2% of the patients at 48 
and 96 hour intervals respectively. While CAM-positive patients made up only 9% of the 
patients in the 48-hour interval and 3.7% in the 96-hour interval. Lastly, CAM-positive patients 
received a higher number of sedatives when compared to CAM-negative patients.    
Delirium Monitoring 
A key factor to the improvement of delirium management and improvement in patient 
outcomes is adherence to routine delirium monitoring of ICU patients for delirium 
(Pandharipande et al., 2005). This study measured adherence to delirium monitoring and found 
that, especially at the 48-hour interval, it was lacking at only 58.1%. This finding did not differ 
from another study that looked at adherence to routine delirium monitoring. Devlin et al. (2008) 
found that less than half of the ICU nurses surveyed perform regular delirium assessment even 
though their hospital protocol expressly included routine delirium monitoring. A specific factor 
that could explain why adherence was not higher during this study is because this ICU is 
critically short staffed. This ICU must rely on staff from other ICUs and the critical care float 
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pool to have an adequate number of staff during a shift. It was not feasible to provide these non-
regular staff members with education on how and when to conduct the CAM-ICU assessment. 
Therefore, these nurses could have skewed the results for adherence to delirium monitoring. This 
failure to assess for delirium could have also altered the incidence of delirium in this study. 
Roughly 40% of the patients at the 48-hour interval failed to have a delirium assessment 
completed.  
Incidence of Delirium  
The incidence of delirium in this study was found to be low (9%), while current research 
shows delirium to be much more prevalent, up to 80%, among ICU patients (Pandharipande et 
al., 2005). Certain risk factors have been “positively and significantly associated with the 
development of delirium in the ICU: preexisting dementia; history of hypertension and/or 
alcoholism; and a high severity of illness” (Barr et al., 2013, p. 286). One of these risk factors 
that could have been lower in the patients in the study was the acuity of the illness of these 
patients. The severity of illness can be measured using the APACHE II. However, the admitting 
services currently do not document the severity of illness using a scoring system, so no data was 
able to be compiled. A comparison of this data would have led to a greater understanding if these 
patients were at a lower risk for delirium than other ICU patients thus possibility explaining the 
low incidence of delirium found.  
Previous studies have shown that age is also a risk factor for the development of delirium 
but the patients of this study were relativity young, with a mean age of 53.2 (Pandharipande et 
al., 2006; Barr et al., 2013). Truman and Ely (2003) identified that with regards to age, over 
seventy, place a patient at risk for the development of delirium. The younger age of this study’s 
population could have decreased their risk factor for the development of delirium and thus the 
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incidence of delirium in this study. When this relative young age was combined with the possible 
decreased severity of illness, an overall decrease in risk for delirium could have existed among 
these patients. These decreased risks could explain why this study had a lower prevalence of 
delirium when compared with previous studies.  
Sedatives/Analgesic and CAM-Positive Patients  
Overall, the CAM-positive patients received a higher average number of dosages of both 
analgesic and sedative medications when compared with the CAM-negative patients (see figure 3 
for the comparison of analgesic medications: CAM-positive vs. CAM-negative and Figure 4 for 
the comparison of sedative medications: CAM-positive vs. CAM-negative). Due to the small 
sample size of CAM-positive patients a statistical inference could not be determined. However, 
this finding was consistent with previous studies that found a statistical significant association 
between sedative medications usage and an increased incidence of delirium (Barr et al., 2013; 
Pandharipande et al., 2006). The increased analgesic mediations usage in delirium positive 
patients was also consistent with previous studies, which found a correlation between those 
medications and delirium (Barr et al., 2013; Pandharipande et al., 2006). Also noted within this 
study was the under use of Precedex as an alternative to continuous benzodiazepine infusions, 
1.8% versus 9% respectively. According to the current guidelines, Precedex is recommended 
over the use of benzodiazepines in patients not suffering for alcohol withdrawal to decrease the 
incidence of delirium in ICU patients (Barr et al., 2013).    
Sedative and analgesic medications were mostly prescribed as PRN doses. Therefore, the 
nurses were highly responsible for the amount of medications the patients received during the 
time intervals. This ability of the nurse to influence the type and amount of medications given to 
a patient could have implications in terms of the development of delirium. This study did not 
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evaluate the surgical ICU nurses knowledge of delirium. However, a high possibility exists that 
these nurses did not have an evidence-based understanding of delirium (recognition of risks and 
prevention). Currently, staff development on delirium is not provided by the education 
department at the hospital, nor has there been quality improvement initiatives on evidence-based 
delirium guidelines. Devlin et al. (2008) found that nurses who do not routinely monitor for 
delirium lack the following knowledge: “(1) delirium is an underdiagnosed problem in the ICU, 
(2) patients with delirium are often hypoactive, (3) nondrug therapy should be generally 
considered before antipsychotic therapy, and (4) delirium is often associated with fluctuating 
signs and symptoms” (p. 563). This lack of knowledge could lead to failure to identify delirium, 
especially hypoactive delirium; the over administering of medications known to increase risk of 
and underuse of non-pharmacological interventions to prevent/treat delirium in ICU patients.    
Limitations 
Several limitations existed in this study. Generalization of the results from this study 
cannot be made because this study was a single-center study. The data were obtained from a 
retrospective chart review, which means the results of the study relied upon the accuracy of the 
documentation. The accuracy of the data also relied on the ability of the surgical ICU nurses to 
conduct the CAM-ICU assessment appropriately and adhere to evidence-based protocols. The 
acuity of the patients in the study could not be compared because the providers do not document 
the APACHE II score in their progress notes or in the history and physical. Data from all patients 
that met the inclusion/exclusion criteria were included in the study, but the sample size was 
small. Statistical inferences about the data could not be made as a result of the small sample size 
of CAM-positive patients.              
 




Implications for Practice  
An important implication for practice would be to develop a delirium protocol that 
included identification of high risk patients, e.g. “preexisting dementia, history of hypertension 
and/or alcoholism and a high severity of illness”, routine monitoring with the CAM-ICU tool 
once a shift, notification of provider of CAM-ICU positive patients, and preventive measures 
(Barr et al., 2013, p.286). Preventive measures would be early mobilization of patients, daily 
sedation vacations, avoid administering continuous infusions of benzodiazepines and instead use 
Precedex (with the exception of patients withdrawing from alcohol), and promotion of sleep 
wake cycle (Barr et al., 2013). Provider notification is important because then “clinicians will be 
able to address reversible causes of delirium and avoid initiating treatments for agitation known 
to worsen delirium, e.g. benzodiazepines” (Devlin, Brummel, & Al-Qadheeb, 2012, p. 386). 
Even though this study specifically focused on the ICU, any patients within the hospital can 
experience delirium; estimating to occur in 60% of non-ICU patients when they have three or 
more risk factors (Truman & Ely, 2003). Therefore, it would be important to include all patients 
in the hospital in the delirium protocol. Implementing delirium monitoring for all patients could 
lead to an improvement in identification and treatment of delirium.  
Prior to this study the majority of the nurses had never used the CAM-ICU assessment 
tool, with the expectations of the travel nurses that had monitored for delirium at other facilities. 
Even though education was provided on how to use the tool appropriately, the likelihood that 
some nurses did not accurately assess patients is a concern. Therefore, a practice implications 
would be to provide all nurses with extensive education on how to perform the CAM-ICU 
assessment. A study found that the best implementation of the CAM-ICU assessment resulted 
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after extensive education was provided, as well as frequent reminders for the staff to evaluate 
each patient for delirium and consistent evaluations on the ability of the nurses to implement the 
tool (Devlin et al., 2012). This can be accomplished by having the nursing education department 
adapt the CAM-ICU assessment education into their new hire nursing education class and 
requiring current staff to attend an educational presentation during yearly competencies.       
Along with the education on the CAM-ICU assessment the nurses need to be provided 
with evidence-based education on delirium (Gusmao-Flores et al., 2012). Delirium needs to be 
understood in terms of an acute cognitive dysfunction of the brain and should be given as high of 
a priority as any other organ dysfunction, e.g. heart, kidney, or liver (Pandharipande et al., 2005). 
A lack of knowledge about risk factors associated with delirium, among nurses, can further 
increase its incidence among patients (Arend & Christensen, 2009; Pandharipande et al., 2005). 
For example, in this study the nurses continued to administer medications known to exacerbate 
delirium even after patients tested positive for delirium.  
Implications for Future Inquiry  
 A Future study in the area of delirium needs to be on how to decrease the incidence 
through non-pharmacologic preventive measures that specifically examine ICU patients that 
experience delirium. The current research that is available on preventive measures for delirium, 
with the exception of early mobilization, were conducted on non-ICU patients (Barr et al., 2013). 
Therefore, these findings may not be transferable to ICU patients experiencing delirium (Barr et 
al., 2013; Truman & Ely, 2003). Until more studies are conducted on non-pharmacologic 
prevention measures for delirium in the ICU, evidence-based guidelines are limited.   
Future research also needs to focus on evidence-based pharmacological treatment of 
delirium in the ICU patient. Currently, there is a lack of randomized controlled trials (RCTs) that 
MONITORING FOR DELIRIUM IN THE INTENSIVE CARE UNIT 
21 
 
show a consistent way to treat delirium among ICU patients (Barr et al., 2013; Devlin & Skrobik, 
2011). One small study found that quetiapine, an atypical antipsychotic, may reduce delirium in 
ICU patients but more studies need to occur to confirm whether this finding is generalizable to 
all ICU patients that experience delirium (Barr et al., 2013). Therefore, until more research is 
available evidence-based guidelines for the pharmacological treatment of delirium is extremely 
limited.   
Conclusion  
Required routine delirium monitoring should occur per evidence-based practice 
guidelines. The incidence of delirium in this study was found to be low, at 9%, when compared 
to previous studies on delirium. No statistically significant conclusions could be drawn from this 
study. CAM-ICU positive patients received more sedative medications than CAM-negative 
patients in this study. This finding is consistent with previous studies that linked administration 
of sedative medications, specifically benzodiazepines, and the development of delirium 
(Pandharipande et al., 2006; Robinson et al., 2008). The next step beyond this study is to 
implement a set delirium protocol that will require routine delirium monitoring of patients, 
institute preventive measures, and limit the use of delirium exacerbating medications. Future 
studies will need to focus on prevention and treatment by non-pharmacological and 
pharmacological means, specifically for ICU patients. In conclusion, this single study may have 
found a low incidence of delirium among these specific ICU patients but many previous studies 
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Table 1.  
Demographics of Sample 
Demographics of Sample  
 (n=76) 
Age, years mean  53.2 
Sex   
     Male 
     Female  
43 (56.6%) 
33 (43.4%) 
Race   
      Caucasian 
      African American  




Admitting Service   
      Trauma 
      Medical ICU 
      Neurosurgery  
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Table 2.  
Adherence to Delirium Monitoring 
Adherence to Delirium Monitoring     
 48 hours 96 hours 
(n=76) (n=55) 
       Discharged from ICU prior to 48 or 96   
       hour evaluation   
21 (27.6%) 28 (51%) 
 (n=55) (n=27) 
       Documented at 8am and 8pm 
       Documented only once 
       Not documented  
32 (58.1%) 22 (81.4%) 
16 (29.1%) 3 (11.1%) 
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Table 3.  
CAM-ICU Results 
CAM-ICU Results  
 48 hours post admission 
(n=76) 
96 hours post admission 
(n=55) 
Discharged prior to 
evaluation  
21 (27.6%) 28 (51%) 
 (n=55) (n=27) 
Negative  36 (65.5%) 16 (59.2%) 
Positive 5 (9%) 1 (3.7%) 
 
Note. Two groups excluded from this table were: unable to assess (10.9% at 24-hours and 29.6% 
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Table 4.  
Breakdown of Medication Administered 
Breakdown of Medications Administered 
 Total Subjects 
Analgesics (n=55) 
 Opioids  
   Percocet 5/325mg 11 (20%) 
   Morphine  
      Oral 1 (1.8%) 
      Intravenous 20 (36.3%) 
   Dilaudid 20 (36.3%) 
   Fentanyl  
      Intravenous Push 6 (10.9%) 
      Continuous    10 (18.2%) 
   Norco    18 (32.7%) 
   Oxycodone 13 (23.6%) 
   Roxicet 1 (1.8%) 
Sedatives  
   Precedex Infusion 1 (1.8%) 
   Ativan  
     Oral 2 (3.6%) 
     Intravenous 2 (3.6%) 
   Propofol Infusion 3 (5.5%) 
   Versed  
     Intravenous Push 6 (10.9%) 
     Continuous 5 (9%) 
   Valium 1 (1.8%) 
Antipsychotic  
    Haldol        1 (1.8%) 
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Figure 3. Comparison Analgesic Medications: CAM-Positive vs. CAM-Negative. 
 
Note. SD ± 0.1(24hr), 0.2(48hr), 0.9(72hr), 0.9(96hr). CAM-negative patients n=39. CAM-
positive patients n=5. CAM-positive defined as any patient that tested positive for delirium at 




















24 hours 48 hours 72 hours 96 hours
CAM-Positive Average Analgesic
Medication Dosages
1.6 2.6 3.8 3.4
CAM-Negative Average Analgesic
Medication Dosages
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Figure 4. Comparison Sedative Medications: CAM-Positive vs. CAM-Negative. 
 
Note. SD ± 0.9(24hr), 0.4(48hr), 0.2(72hr), 0.6(96hr). CAM-negative patients n=39. CAM-
positive patients n=5. CAM-positive defined as any patient that tested positive for delirium at 
any point during the 96-hour interval. 
24 hours 48 hours 72 hours 96 hours
CAM-Positive Average Sedative
Medication Dosages
3 1.2 2 2.7
CAM-Negative Average Sedative
Medication Dosages
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